8-KOther Events

ELI LILLY & Co 8-K Report (Aug 14, 2002)

Filed August 14, 2002For Securities:LLY

Summary

Eli Lilly & Co. (LLY) filed a Current Report on Form 8-K on August 14, 2002, primarily to disclose the submission of sworn statements by its Chief Executive Officer and Chief Financial Officer to the SEC. This action was taken in response to a specific SEC order related to the Sarbanes-Oxley Act's precursors and accounting oversight. The sworn statements relate to the accuracy of the company's 2001 annual report on Form 10-K, its 2002 definitive proxy materials, and all subsequent quarterly (10-Q) and current (8-K) reports filed after the 2001 10-K. The statements were submitted without exceptions or modifications, indicating the company's compliance with the SEC's directive to affirm the integrity of these key financial and governance disclosures.

Key Highlights

  • 1Eli Lilly & Co. (LLY) filed an 8-K on August 14, 2002.
  • 2The filing pertains to sworn statements submitted by the CEO and CFO to the SEC.
  • 3These statements were made in response to an SEC order regarding financial reporting accuracy.
  • 4The sworn statements cover the 2001 Form 10-K, 2002 proxy materials, and subsequent 10-Q and 8-K filings.
  • 5The statements were submitted without exceptions or modifications.
  • 6This action reflects a heightened focus on corporate accountability and financial disclosure integrity in 2002.
  • 7Charles E. Golden, EVP and CFO, signed the report on behalf of the company.

Frequently Asked Questions

The main purpose of this 8-K filing is to report that Eli Lilly's Chief Executive Officer and Chief Financial Officer have submitted sworn statements to the SEC. These statements attest to the accuracy of the company's key financial and governance filings made after the 2001 annual report.

The sworn statements were required by a specific SEC order issued in the context of increased scrutiny over corporate accounting practices and financial reporting, preceding the full implementation of the Sarbanes-Oxley Act.

The sworn statements cover the accuracy of Eli Lilly's 2001 Form 10-K annual report, its 2002 definitive proxy materials, and all subsequent Forms 10-Q and 8-K filed after the 2001 10-K.

No, the filing states that the sworn statements were made 'without exceptions or modifications.' This suggests the company is affirming the accuracy of its previously filed documents as directed by the SEC, rather than disclosing new problems.